Summary of opinion: Metalyse, 14/12/2023 Positive
Submitted by Anonymous (not verified) on 7 November 2024 - 8:54
Summary of opinion: Metalyse, 14/12/2023 Positive
Veterinary medicines European public assessment report (EPAR): Versican Plus Pi/L4, canine parainfluenza virus and Leptospira, Status: Authorised
Submitted by Anonymous (not verified) on 6 November 2024 - 16:35
Veterinary medicines European public assessment report (EPAR): Versican Plus Pi/L4, canine parainfluenza virus and Leptospira, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Versican Plus Pi, canine parainfluenza virus, Status: Authorised
Submitted by Anonymous (not verified) on 6 November 2024 - 16:26
Veterinary medicines European public assessment report (EPAR): Versican Plus Pi, canine parainfluenza virus, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Versican Plus L4, Canine leptospirosis vaccine (inactivated), Status: Authorised
Submitted by Anonymous (not verified) on 6 November 2024 - 16:22
Veterinary medicines European public assessment report (EPAR): Versican Plus L4, Canine leptospirosis vaccine (inactivated), Status: Authorised
Veterinary medicines European public assessment report (EPAR): Innovax-ND-IBD, Newcastle disease, infectious bursal disease and Marek's disease vaccine (live recombinant), Status: Authorised
Submitted by Anonymous (not verified) on 6 November 2024 - 16:10
Veterinary medicines European public assessment report (EPAR): Innovax-ND-IBD, Newcastle disease, infectious bursal disease and Marek's disease vaccine (live recombinant), Status: Authorised
Veterinary medicines European public assessment report (EPAR): Vaxxitek HVT+IBD, Infectious bursal disease and Marek's disease vaccine (live recombinant), Status: Authorised
Submitted by Anonymous (not verified) on 6 November 2024 - 16:00
Veterinary medicines European public assessment report (EPAR): Vaxxitek HVT+IBD, Infectious bursal disease and Marek's disease vaccine (live recombinant), Status: Authorised
Veterinary medicines European public assessment report (EPAR): Poulvac E. coli, Escherichia coli aroA gene deleted, type O78, strain EC34195 (live), Status: Authorised
Submitted by Anonymous (not verified) on 6 November 2024 - 15:30
Veterinary medicines European public assessment report (EPAR): Poulvac E. coli, Escherichia coli aroA gene deleted, type O78, strain EC34195 (live), Status: Authorised
Veterinary medicines European public assessment report (EPAR): Porcilis PCV M Hyo, porcine circovirus type 2 ORF2 subunit antigen,mycoplasma hyopneumoniae vaccine (inactivated), Status: Authorised
Submitted by Anonymous (not verified) on 6 November 2024 - 15:30
Veterinary medicines European public assessment report (EPAR): Porcilis PCV M Hyo, porcine circovirus type 2 ORF2 subunit antigen,mycoplasma hyopneumoniae vaccine (inactivated), Status: Authorised
Human medicines European public assessment report (EPAR): Byetta, exenatide, Date of authorisation: 20/11/2006, Revision: 30, Status: Authorised
Submitted by Anonymous (not verified) on 6 November 2024 - 15:28
Human medicines European public assessment report (EPAR): Byetta, exenatide, Date of authorisation: 20/11/2006, Revision: 30, Status: Authorised
European Shortages Monitoring Platform (ESMP): Implementation guide for national competent authorities
Submitted by Anonymous (not verified) on 6 November 2024 - 14:10
European Shortages Monitoring Platform (ESMP): Implementation guide for national competent authorities